| Market Cap | ₹53Cr |
| ROE | 25.60% |
| P/E Ratio(TTM) | 1.54 |
| EPS(TTM) | 0.28 |
| P/B Ratio | 0.40 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.95 |
| Book Value | 1.09 |
| Debt to Equity | 0.92 |
| Face Value | 1 |
| Parent Organisation | Welcure Drugs & Pharmaceuticals Limited |
| Managing Director | Shri. Sudhir Chandra |
| BSE Symbol | 524661 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.24 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.49 | ||
| Wockhardt | NA (0.00%) | -453.55 | ||
| Cohance Lifesciences | NA (0.00%) | 64.99 |